149 related articles for article (PubMed ID: 33811994)
1. Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans.
Teymuri M; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Bioorg Med Chem Lett; 2021 Jun; 41():128013. PubMed ID: 33811994
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans.
Nóbrega RO; Teixeira AP; Oliveira WA; Lima EO; Lima IO
Pharm Biol; 2016 Nov; 54(11):2591-2596. PubMed ID: 27225838
[TBL] [Abstract][Full Text] [Related]
3. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.
Pereira de Sá N; Lino CI; Fonseca NC; Borelli BM; Ramos JP; Souza-Fagundes EM; Rosa CA; Santos DA; Barbosa de Oliveira R; Johann S
Eur J Med Chem; 2015 Sep; 102():233-42. PubMed ID: 26276437
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
5. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity study of the monoterpene thymol against
Teixeira APC; Nóbrega RO; Lima EO; Araújo WO; Lima IO
Nat Prod Res; 2020 Sep; 34(18):2630-2633. PubMed ID: 30584769
[No Abstract] [Full Text] [Related]
7. Fisetin as a promising antifungal agent against Cryptocococcus neoformans species complex.
Reis MP; Carvalho CR; Andrade FA; Fernandes OF; Arruda W; Silva MR
J Appl Microbiol; 2016 Aug; 121(2):373-9. PubMed ID: 27107205
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic.
Takesako K; Kuroda H; Inoue T; Haruna F; Yoshikawa Y; Kato I; Uchida K; Hiratani T; Yamaguchi H
J Antibiot (Tokyo); 1993 Sep; 46(9):1414-20. PubMed ID: 8226319
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of the antifungal and antibiofilm activities of plumbagin against
Qian W; Wang W; Zhang J; Fu Y; Liu Q; Li X; Wang T; Zhang Q
Biofouling; 2022 Jul; 38(6):558-574. PubMed ID: 35818738
[No Abstract] [Full Text] [Related]
10. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
[TBL] [Abstract][Full Text] [Related]
11. Scaffold hopping of sampangine: discovery of potent antifungal lead compound against Aspergillus fumigatus and Cryptococcus neoformans.
Jiang Z; Liu N; Dong G; Jiang Y; Liu Y; He X; Huang Y; He S; Chen W; Li Z; Yao J; Miao Z; Zhang W; Sheng C
Bioorg Med Chem Lett; 2014 Sep; 24(17):4090-4. PubMed ID: 25115626
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Natural Acylphloroglucinol-Based Antifungal Compounds against Cryptococcus Species.
Yu Q; Ravu RR; Jacob MR; Khan SI; Agarwal AK; Yu BY; Li XC
J Nat Prod; 2016 Sep; 79(9):2195-201. PubMed ID: 27584935
[TBL] [Abstract][Full Text] [Related]
13. A potential of propolis on major virulence factors of Cryptococcus neoformans.
Thammasit P; Iadnut A; Mamoon K; Khacha-Ananda S; Chupradit K; Tayapiwatana C; Kasinrerk W; Tragoolpua Y; Tragoolpua K
Microb Pathog; 2018 Oct; 123():296-303. PubMed ID: 30041002
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
15. Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Zhu T; Chen X; Li C; Tu J; Liu N; Xu D; Sheng C
Eur J Med Chem; 2021 Oct; 221():113524. PubMed ID: 33992927
[TBL] [Abstract][Full Text] [Related]
16. Effect of
Musavinasab-Mobarakeh SA; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Curr Med Mycol; 2021 Mar; 7(1):38-43. PubMed ID: 34553096
[TBL] [Abstract][Full Text] [Related]
17. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.
Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240
[TBL] [Abstract][Full Text] [Related]
18. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
19. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
[TBL] [Abstract][Full Text] [Related]
20. The "in vitro" antifungal activity evaluation of propolis G12 ethanol extract on Cryptococcus neoformans.
Fernandes FF; Dias AL; Ramos CL; Ikegaki M; de Siqueira AM; Franco MC
Rev Inst Med Trop Sao Paulo; 2007; 49(2):93-5. PubMed ID: 17505666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
